AI Liquid Biopsy Detects Early Liver Disease

Researchers at Johns Hopkins University developed an AI-driven blood test to detect early liver disease ^[3]. The technology analyzes cell-free DNA fragments to find signs of fibrosis and cirrhosis ^[1]. This method identifies chronic conditions years before patients show symptoms ^[2]. The test focuses on genome-wide fragmentation patterns in the blood ^[2]. Using artificial intelligence, the system recognizes specific signals associated with liver damage ^[3]. This liquid biopsy offers a non-invasive alternative to traditional diagnostic methods ^[1][3].